Baylor University

Guthrie Ophthalmologist Named Catholic Doctor of the Year

Retrieved on: 
Friday, November 17, 2023

In 1988, she went on her first medical mission trip to a Catholic Mission Hospital in Abak, Nigeria.

Key Points: 
  • In 1988, she went on her first medical mission trip to a Catholic Mission Hospital in Abak, Nigeria.
  • In 2006, Dr. Schanzer and her husband, at the invitation of local Archbishop Joseph Ganda, established Southern Eye Clinic in Serabu, Sierra Leone.
  • Today, Southern Eye Clinic of Serabu is open year-round, providing diagnostic examinations, medicines, eyeglasses, and modern eye surgery free of charge to all patients.
  • Dr. Schanzer and her husband are grateful for their deep faith and the strong worldwide support of family and friends.

Global COVID-19 Monument Design Competition Winner Announced

Retrieved on: 
Friday, November 17, 2023

CHICAGO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The COVID-19 Monument Commission announces the winner of their global design contest for the COVID-19 Monument of Honor, Remembrance, and Resilience, scheduled to unveil spring 2025 in Chicago, Illinois.

Key Points: 
  • CHICAGO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The COVID-19 Monument Commission announces the winner of their global design contest for the COVID-19 Monument of Honor, Remembrance, and Resilience, scheduled to unveil spring 2025 in Chicago, Illinois.
  • Professor Schachner earned her BFA in Sculpture from Baylor University and her MFA in Studio Art from the University of Montana.
  • These events contributed to her visceral and personal reactions navigating the pandemic in the early lockdown days and resonated in her desire to create a design for the Hektoen COVID-19 Monument competition.
  • Corporate sponsorships will provide worldwide recognition at the monument site and on the website, which will offer in perpetuity a virtual platform for the global pandemic experience.

Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer

Retrieved on: 
Wednesday, December 6, 2023

Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, today announced that Rizwan Velji has been appointed Chief Business Officer (CBO).

Key Points: 
  • Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, today announced that Rizwan Velji has been appointed Chief Business Officer (CBO).
  • View the full release here: https://www.businesswire.com/news/home/20231206761602/en/
    Rizwan Velji has joined Alentis Therapeutics as Chief Business Officer (Photo: Alentis Therapeutics)
    “Rizwan possesses an incredible depth of experience in corporate and financial strategy for biotech companies,” said Roberto Iacone, Chief Executive Officer of Alentis.
  • Rizwan Velji said, “I am very excited to be joining Alentis at this critical juncture in their life cycle, as they rapidly advance their lead candidates through early clinical development.
  • My goal is to support the growth and evolution of the company further securing Alentis’ leading position in Claudin-1 biology.

Ryan Promotes Nine to Leadership Role of Principal Across Four Practice Areas

Retrieved on: 
Thursday, December 7, 2023

Ryan , a leading global tax services and software provider, recently announced the promotion of nine professionals to the leadership role of principal in seven locations across the United States.

Key Points: 
  • Ryan , a leading global tax services and software provider, recently announced the promotion of nine professionals to the leadership role of principal in seven locations across the United States.
  • They have continued to provide world-class service to our clients, built and managed successful teams, and have always found ways to push through challenges.
  • He holds two bachelor’s degrees in marketing and business administration from the Culverhouse College of Business at The University of Alabama.
  • He is a CPA and holds a Bachelor of Science degree with specialization in accounting from the University of Illinois-Chicago.

Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome

Retrieved on: 
Thursday, November 30, 2023

NGN-401 is an investigational adeno-associated virus (AAV) gene therapy candidate for Rett syndrome purposefully designed and administered to maximize the therapeutic activity while averting transgene overexpression toxicities.

Key Points: 
  • NGN-401 is an investigational adeno-associated virus (AAV) gene therapy candidate for Rett syndrome purposefully designed and administered to maximize the therapeutic activity while averting transgene overexpression toxicities.
  • NGN-401 delivers the full-length human methyl cytosine binding protein 2 (MECP2) gene, providing an optimal gene replacement approach.
  • In non-clinical studies with NGN-401 at clinically relevant doses, cardinal features of Rett syndrome were ameliorated, and no overexpression toxicity was observed.
  • Your resilience, courage, and support not only contribute to the progress of this research, but also inspire hope within the entire Rett syndrome community.

Novosound Expands Healthcare and Wearable Ultrasound Operations in US

Retrieved on: 
Tuesday, November 28, 2023

Scottish startup Novosound has expanded its healthcare and wireless wearable ultrasound operations in the US.

Key Points: 
  • Scottish startup Novosound has expanded its healthcare and wireless wearable ultrasound operations in the US.
  • View the full release here: https://www.businesswire.com/news/home/20231128490755/en/
    Novosound's wearable ultrasound technology set to advance vital signs monitoring.
  • Overall, we’re demonstrating that we’re at the forefront of ultrasound sensor technology, and our clients are helping us achieve our vision, which we describe as ‘Ultrasound.
  • Everywhere.’”
    - Novosound will be featuring at Pumps & Pipes in Houston on December 4, and CES 2024 9-12 January.

NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the Treatment of Complicated Urinary Tract Infections

Retrieved on: 
Monday, December 18, 2023

"Complicated Urinary Tract Infections afflict approximately 3 million Americans each year, and pathogens have become increasingly resistant to commonly used antibiotics.

Key Points: 
  • "Complicated Urinary Tract Infections afflict approximately 3 million Americans each year, and pathogens have become increasingly resistant to commonly used antibiotics.
  • New treatment options are urgently needed" stated Jonathan Javitt, MD MPH, Founder and Chief Scientist of NRx Pharmaceuticals.
  • "The D-cycloserine (DCS) component of NRX-101 is well known as an antibiotic and is excreted unmetabolized in the urine.
  • The company awaits the FDA's response to its request for Qualified Infectious Disease Product (QIDP) designation, expected next month.

Academic Influence Ranks the Colleges with the Most Cheerful Christmas Traditions

Retrieved on: 
Wednesday, December 13, 2023

DENTON, Texas, Dec. 13, 2023 /PRNewswire/ -- AcademicInfluence.com is pleased to announce their article, "Colleges with the Most Cheerful Christmas Traditions."

Key Points: 
  • DENTON, Texas, Dec. 13, 2023 /PRNewswire/ -- AcademicInfluence.com is pleased to announce their article, "Colleges with the Most Cheerful Christmas Traditions."
  • Using its proprietary InfluenceRanking™ Engine—innovative machine-learning technology that objectively measures a school's influence through its students, faculty, staff, and alumni—Academic Influence ranks academic persons, institutions, and disciplinary programs.
  • Academic Influence writes that both Christian and secular schools participate in Christmas traditions on campus.
  • Academic Influence's ranking of the colleges with the most cheerful Christmas traditions was written to inform students and communities of college campuses about ways to join the spirit of the season through campus traditions and celebrations.

Maya Barsky, MD, MSCI Joins the Center for Advanced Reproductive Services as a Lead Physician

Retrieved on: 
Tuesday, December 12, 2023

FARMINGTON, Conn., Dec. 12, 2023 /PRNewswire/ -- The Center for Advanced Reproductive Services, one of the leading family building programs in the country, announced Dr. Maya Barsky, reproductive endocrinologist, has joined as Lead Physician and Assistant Professor in the Department of Ob/Gyn at UConn School of Medicine.

Key Points: 
  • FARMINGTON, Conn., Dec. 12, 2023 /PRNewswire/ -- The Center for Advanced Reproductive Services, one of the leading family building programs in the country, announced Dr. Maya Barsky, reproductive endocrinologist, has joined as Lead Physician and Assistant Professor in the Department of Ob/Gyn at UConn School of Medicine.
  • "I am very fortunate to be a part of such a respected and successful program as the Center for Advanced Reproductive Services."
  • Dr. Barsky is available to connect with patients via telehealth appointments effective immediately, with in-person appointments beginning in January 2024.
  • Prior to joining The Center for Advanced Reproductive Services, she was part of a private fertility practice in Austin, TX for several years.

Texas Children's Hospital Receives 4.8 Million Dollar Transformational Corporate Gift to Fund Behavioral Health Initiative

Retrieved on: 
Wednesday, December 6, 2023

HOUSTON, Dec. 6, 2023 /PRNewswire/ -- Texas Children's Hospital is thrilled to announce that Ovintiv Inc. , a leading North American exploration and production company, has pledged 4.8 million to fund its new behavioral health Intensive Outpatient Program (IOP) at Texas Children's Hospital The Woodlands .

Key Points: 
  • HOUSTON, Dec. 6, 2023 /PRNewswire/ -- Texas Children's Hospital is thrilled to announce that Ovintiv Inc. , a leading North American exploration and production company, has pledged 4.8 million to fund its new behavioral health Intensive Outpatient Program (IOP) at Texas Children's Hospital The Woodlands .
  • "Our partnership with Texas Children's Hospital is a natural fit," said Brendan McCracken, President & CEO of Ovintiv.
  • Ovintiv's generous pledge makes them the first company member of the Council for Hope, Texas Children's new Corporate Giving Society, whose fundraising priorities include supporting Texas Children's behavioral health initiatives.
  • In 2022, Texas Children's formed a dedicated Behavioral Health Task Force to implement new and expanded services for patients in need of specialized care.